- Recce Pharmaceuticals (RCE) has begun the process to dual list on the Frankfurt Stock Exchange (FSE)
- The company has appointed Deutsche Gesellschaft Für Wertpapieranalyse (DGWA) as its investor and corporate relations advisor in Europe
- DGWA will engage prospective investors and drive awareness of Recce's productsDual listing on the FSE will give Recce exposure to multiple retail and institutional investors in the European Union
- The company will keep the market updated as the listing progresses Shares in Recce are steady on the market and are trading at $1.05 per share
Read the full article on The Market Herald here.
- Forums
- ASX - By Stock
- RCE
- Recce Pharmaceuticals (ASX:RCE) to dual list on FSE
RCE
recce pharmaceuticals ltd
Add to My Watchlist
1.72%
!
29.5¢

Recce Pharmaceuticals (ASX:RCE) to dual list on FSE
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $83.62M |
Open | High | Low | Value | Volume |
29.0¢ | 32.0¢ | 29.0¢ | $25.51K | 83.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8308 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 7696 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8308 | 0.295 |
3 | 20189 | 0.290 |
5 | 156043 | 0.285 |
12 | 364806 | 0.280 |
4 | 37019 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 7696 | 4 |
0.310 | 11461 | 2 |
0.315 | 2802 | 2 |
0.325 | 789 | 1 |
0.330 | 114286 | 2 |
Last trade - 14.16pm 25/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |